202 related articles for article (PubMed ID: 22011144)
1. Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA).
Zha Z; Choi SR; Ploessl K; Lieberman BP; Qu W; Hefti F; Mintun M; Skovronsky D; Kung HF
J Med Chem; 2011 Dec; 54(23):8085-98. PubMed ID: 22011144
[TBL] [Abstract][Full Text] [Related]
2. (68)Ga-Bivalent Polypegylated Styrylpyridine Conjugates for Imaging Aβ Plaques in Cerebral Amyloid Angiopathy.
Zha Z; Song J; Choi SR; Wu Z; Ploessl K; Smith M; Kung H
Bioconjug Chem; 2016 May; 27(5):1314-23. PubMed ID: 27045547
[TBL] [Abstract][Full Text] [Related]
3. Novel styrylpyridines as probes for SPECT imaging of amyloid plaques.
Qu W; Kung MP; Hou C; Benedum TE; Kung HF
J Med Chem; 2007 May; 50(9):2157-65. PubMed ID: 17411026
[TBL] [Abstract][Full Text] [Related]
4. 99mTc(CO)3-Labeled Benzothiazole Derivatives Preferentially Bind Cerebrovascular Amyloid: Potential Use as Imaging Agents for Cerebral Amyloid Angiopathy.
Jia J; Cui M; Dai J; Liu B
Mol Pharm; 2015 Aug; 12(8):2937-46. PubMed ID: 26065726
[TBL] [Abstract][Full Text] [Related]
5. 18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.
Zhang W; Kung MP; Oya S; Hou C; Kung HF
Nucl Med Biol; 2007 Jan; 34(1):89-97. PubMed ID: 17210465
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques.
Cui M; Wang X; Yu P; Zhang J; Li Z; Zhang X; Yang Y; Ono M; Jia H; Saji H; Liu B
J Med Chem; 2012 Nov; 55(21):9283-96. PubMed ID: 22974116
[TBL] [Abstract][Full Text] [Related]
7. Development of a PET radioligand selective for cerebral amyloid angiopathy.
Abrahamson EE; Stehouwer JS; Vazquez AL; Huang GF; Mason NS; Lopresti BJ; Klunk WE; Mathis CA; Ikonomovic MD
Nucl Med Biol; 2021 Jan; 92():85-96. PubMed ID: 32471773
[TBL] [Abstract][Full Text] [Related]
8. Novel ¹⁸F-labeled benzoxazole derivatives as potential positron emission tomography probes for imaging of cerebral β-amyloid plaques in Alzheimer's disease.
Cui M; Ono M; Kimura H; Ueda M; Nakamoto Y; Togashi K; Okamoto Y; Ihara M; Takahashi R; Liu B; Saji H
J Med Chem; 2012 Nov; 55(21):9136-45. PubMed ID: 22690944
[TBL] [Abstract][Full Text] [Related]
9. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
10. F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain.
Zhang W; Oya S; Kung MP; Hou C; Maier DL; Kung HF
J Med Chem; 2005 Sep; 48(19):5980-8. PubMed ID: 16162001
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of ¹⁸F-labeled styryltriazole and resveratrol derivatives for β-amyloid plaque imaging.
Lee I; Choe YS; Choi JY; Lee KH; Kim BT
J Med Chem; 2012 Jan; 55(2):883-92. PubMed ID: 22236086
[TBL] [Abstract][Full Text] [Related]
12. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
13. Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.
Han BH; Zhou ML; Vellimana AK; Milner E; Kim DH; Greenberg JK; Chu W; Mach RH; Zipfel GJ
Mol Neurodegener; 2011 Dec; 6():86. PubMed ID: 22192811
[TBL] [Abstract][Full Text] [Related]
14. 18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.
Kung HF; Choi SR; Qu W; Zhang W; Skovronsky D
J Med Chem; 2010 Feb; 53(3):933-41. PubMed ID: 19845387
[No Abstract] [Full Text] [Related]
15. Characterization of IMPY as a potential imaging agent for beta-amyloid plaques in double transgenic PSAPP mice.
Kung MP; Hou C; Zhuang ZP; Cross AJ; Maier DL; Kung HF
Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1136-45. PubMed ID: 15007564
[TBL] [Abstract][Full Text] [Related]
16. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging.
Ryu EK; Choe YS; Lee KH; Choi Y; Kim BT
J Med Chem; 2006 Oct; 49(20):6111-9. PubMed ID: 17004725
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-β plaques may be reduced in advanced stages of cerebral amyloid angiopathy in the elderly.
Okamoto K; Amari M; Fukuda T; Suzuki K; Takatama M
Neuropathology; 2020 Oct; 40(5):474-481. PubMed ID: 32557936
[TBL] [Abstract][Full Text] [Related]
18. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and preliminary evaluation of [
He Y; Zhu X; Wang K; Xie J; Zhu Z; Ni M; Wang S; Xie Q
Bioorg Med Chem; 2022 Dec; 75():117087. PubMed ID: 36356533
[TBL] [Abstract][Full Text] [Related]
20. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain.
Choi SR; Golding G; Zhuang Z; Zhang W; Lim N; Hefti F; Benedum TE; Kilbourn MR; Skovronsky D; Kung HF
J Nucl Med; 2009 Nov; 50(11):1887-94. PubMed ID: 19837759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
